Methods Of Using Alk Inhibitors

Abstract

The invention provides methods for using compounds of Formula (I) for treating an EML4-ALK+ mediated condition such as EML4-ALK+ non-small cell lung cancer, and optionally resistant to crizotinib; wherein R1, R2, R3, R4, R5 and R6 are as defined above.


Claims
Download PDF
Document Preview
Document History
  • Publication: Apr 22, 2014
  • Application: Feb 2, 2012
    US US 201213981046 A
  • Priority: Feb 2, 2012
    US US 201213981046 A
  • Priority: Feb 2, 2012
    US US 2012/0023669 W
  • Priority: Feb 2, 2011
    US US 201161438878 P

Sign in to the Lens

Feedback